Suppression of polymorphonuclear leukocyte bactericidal activity by suramin

E. Roilides, P. Paschalides, A. Freifeld, P. A. Pizzo

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Suramin is a polyanionic compound with potent antineoplastic properties. Because polymorphonuclear leukocytes (PMNs) are a crucial component of host defenses against bacteria and fungi, the effects of suramin on PMN function were studied in vitro. PMNs from healthy donors were incubated with concentrations of suramin of 1 to 1,000 μg/ml (within and exceeding the therapeutic range) for 30 min, and PMN functional parameters were subsequently assessed. Suramin had no effect on viability, chemotaxis to N- formylmethionyl leucyl phenylalanine, phagocytosis of Candida albicans, or superoxide anion production in response to phorbol myristate acetate and formylmethionyl leucyl phenylalanine. Fungicidal activity against C. albicans blastoconidia was unaffected at a suramin concentration of <500 μg/ml, whereas at higher concentrations a slight suppression was observed (P = 0.04). Bactericidal activity against Staphylococcus aureus was significantly suppressed by concentrations of ≥100 μg/ml (P < 0.01). Phagocytosis of S. aureus was also significantly impaired at ≥10 μg/ml (P < 0.05). The presence of 10% human serum during pretreatment did not abrogate the suramin- induced suppression of bactericidal activity. Treatment of PMNs with granulocyte colony-stimulating factor (4,000 U/ml) for 30 min prior to the addition of suramin (250 μg/ml) improved the bactericidal defect (P = 0.02). The PMN functional impairment may be related to increased susceptibility to bacterial infections, and granulocyte colony-stimulating factor may improve the defect.

Original languageEnglish (US)
Pages (from-to)495-500
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume37
Issue number3
DOIs
StatePublished - Jan 1 1993

Fingerprint

Suramin
Neutrophils
N-Formylmethionine Leucyl-Phenylalanine
Granulocyte Colony-Stimulating Factor
Candida albicans
Phagocytosis
Staphylococcus aureus
Tetradecanoylphorbol Acetate
Chemotaxis
Bacterial Infections
Superoxides
Antineoplastic Agents
Fungi
Bacteria
Therapeutics
Serum

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Suppression of polymorphonuclear leukocyte bactericidal activity by suramin. / Roilides, E.; Paschalides, P.; Freifeld, A.; Pizzo, P. A.

In: Antimicrobial Agents and Chemotherapy, Vol. 37, No. 3, 01.01.1993, p. 495-500.

Research output: Contribution to journalArticle

Roilides, E. ; Paschalides, P. ; Freifeld, A. ; Pizzo, P. A. / Suppression of polymorphonuclear leukocyte bactericidal activity by suramin. In: Antimicrobial Agents and Chemotherapy. 1993 ; Vol. 37, No. 3. pp. 495-500.
@article{b26ceb3e38b14969a161e1733642f652,
title = "Suppression of polymorphonuclear leukocyte bactericidal activity by suramin",
abstract = "Suramin is a polyanionic compound with potent antineoplastic properties. Because polymorphonuclear leukocytes (PMNs) are a crucial component of host defenses against bacteria and fungi, the effects of suramin on PMN function were studied in vitro. PMNs from healthy donors were incubated with concentrations of suramin of 1 to 1,000 μg/ml (within and exceeding the therapeutic range) for 30 min, and PMN functional parameters were subsequently assessed. Suramin had no effect on viability, chemotaxis to N- formylmethionyl leucyl phenylalanine, phagocytosis of Candida albicans, or superoxide anion production in response to phorbol myristate acetate and formylmethionyl leucyl phenylalanine. Fungicidal activity against C. albicans blastoconidia was unaffected at a suramin concentration of <500 μg/ml, whereas at higher concentrations a slight suppression was observed (P = 0.04). Bactericidal activity against Staphylococcus aureus was significantly suppressed by concentrations of ≥100 μg/ml (P < 0.01). Phagocytosis of S. aureus was also significantly impaired at ≥10 μg/ml (P < 0.05). The presence of 10{\%} human serum during pretreatment did not abrogate the suramin- induced suppression of bactericidal activity. Treatment of PMNs with granulocyte colony-stimulating factor (4,000 U/ml) for 30 min prior to the addition of suramin (250 μg/ml) improved the bactericidal defect (P = 0.02). The PMN functional impairment may be related to increased susceptibility to bacterial infections, and granulocyte colony-stimulating factor may improve the defect.",
author = "E. Roilides and P. Paschalides and A. Freifeld and Pizzo, {P. A.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1128/AAC.37.3.495",
language = "English (US)",
volume = "37",
pages = "495--500",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Suppression of polymorphonuclear leukocyte bactericidal activity by suramin

AU - Roilides, E.

AU - Paschalides, P.

AU - Freifeld, A.

AU - Pizzo, P. A.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Suramin is a polyanionic compound with potent antineoplastic properties. Because polymorphonuclear leukocytes (PMNs) are a crucial component of host defenses against bacteria and fungi, the effects of suramin on PMN function were studied in vitro. PMNs from healthy donors were incubated with concentrations of suramin of 1 to 1,000 μg/ml (within and exceeding the therapeutic range) for 30 min, and PMN functional parameters were subsequently assessed. Suramin had no effect on viability, chemotaxis to N- formylmethionyl leucyl phenylalanine, phagocytosis of Candida albicans, or superoxide anion production in response to phorbol myristate acetate and formylmethionyl leucyl phenylalanine. Fungicidal activity against C. albicans blastoconidia was unaffected at a suramin concentration of <500 μg/ml, whereas at higher concentrations a slight suppression was observed (P = 0.04). Bactericidal activity against Staphylococcus aureus was significantly suppressed by concentrations of ≥100 μg/ml (P < 0.01). Phagocytosis of S. aureus was also significantly impaired at ≥10 μg/ml (P < 0.05). The presence of 10% human serum during pretreatment did not abrogate the suramin- induced suppression of bactericidal activity. Treatment of PMNs with granulocyte colony-stimulating factor (4,000 U/ml) for 30 min prior to the addition of suramin (250 μg/ml) improved the bactericidal defect (P = 0.02). The PMN functional impairment may be related to increased susceptibility to bacterial infections, and granulocyte colony-stimulating factor may improve the defect.

AB - Suramin is a polyanionic compound with potent antineoplastic properties. Because polymorphonuclear leukocytes (PMNs) are a crucial component of host defenses against bacteria and fungi, the effects of suramin on PMN function were studied in vitro. PMNs from healthy donors were incubated with concentrations of suramin of 1 to 1,000 μg/ml (within and exceeding the therapeutic range) for 30 min, and PMN functional parameters were subsequently assessed. Suramin had no effect on viability, chemotaxis to N- formylmethionyl leucyl phenylalanine, phagocytosis of Candida albicans, or superoxide anion production in response to phorbol myristate acetate and formylmethionyl leucyl phenylalanine. Fungicidal activity against C. albicans blastoconidia was unaffected at a suramin concentration of <500 μg/ml, whereas at higher concentrations a slight suppression was observed (P = 0.04). Bactericidal activity against Staphylococcus aureus was significantly suppressed by concentrations of ≥100 μg/ml (P < 0.01). Phagocytosis of S. aureus was also significantly impaired at ≥10 μg/ml (P < 0.05). The presence of 10% human serum during pretreatment did not abrogate the suramin- induced suppression of bactericidal activity. Treatment of PMNs with granulocyte colony-stimulating factor (4,000 U/ml) for 30 min prior to the addition of suramin (250 μg/ml) improved the bactericidal defect (P = 0.02). The PMN functional impairment may be related to increased susceptibility to bacterial infections, and granulocyte colony-stimulating factor may improve the defect.

UR - http://www.scopus.com/inward/record.url?scp=0027460376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027460376&partnerID=8YFLogxK

U2 - 10.1128/AAC.37.3.495

DO - 10.1128/AAC.37.3.495

M3 - Article

C2 - 7681657

AN - SCOPUS:0027460376

VL - 37

SP - 495

EP - 500

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 3

ER -